Fund Name

$ Value

% Port.

*W EXP 08/31/202

COM NEW

$ Bought

% Increased

% Reduced

$ Sold

Shares

Percent

Date

Type

% Portfolio

% Chg

$ Change

$ Held

# Shares

SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. It focus on development of scientific assets and novel intellectual property across multiple omics fields. The company's True Single Molecule Sequencing technology (tSMS) platform offers a single molecule solution for DNA and RNA sequencing through detection of nucleic acids to researchers for analyzing many billions of single molecules in a single experiment and generate accurate and reproducible data. It provide solutions for various applications, such as biomarker discovery and diagnostic assay developments including laboratories associated with universities, scientific research centers, government institutions, and biotechnology and pharmaceutical companies. In addition, the company has research and development agreement with U.S. Department of Justice's Federal Bureau of Investigation to evaluate and determine the forensic capabilities of direct RNA sequencing using tSMS platform; and research collaboration with True Bearing Diagnostics, Inc. performing tSMS on whole-blood RNA to identify transcripts associated with coronary artery disease. Further, it has collaboration agreement with The Bernstein Laboratory to address fundamental questions in chromatin biology and epigenetic regulation; The Ting Laboratory; The Jackson Laboratory for Genomic Medicine assisting in the development of new methods for chromatin interaction analysis in single nuclei, with single-molecule resolution; Weizmann Institute of Science for developed and applied innovative single-molecule technologies; and Tetracore, Inc. to provide with tSMS systems and onsite support. The company was founded in 2013 and is headquartered in Billerica, Massachusetts.

SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide.

Datesorted ascending	Fund Name	Type	% Portfolio	% Chg	$ Change	$ Held	# Shares
2024-05-13	CLEAR STREET LLC	SOLD OFF	Premium	Premium	Premium	Premium	-
2024-02-14	CITADEL ADVISORS LLC	SOLD OFF	Premium	Premium	Premium	Premium	-
2024-02-14	Cruiser Capital Advisors, LLC	UNCHANGED	Premium	Premium	Premium	Premium	70,000
2024-02-14	Shay Capital LLC	SOLD OFF	Premium	Premium	Premium	Premium	-
2024-02-13	Tower Research Capital LLC (TRC)	SOLD OFF	Premium	Premium	Premium	Premium	-
2024-02-13	MORGAN STANLEY	SOLD OFF	Premium	Premium	Premium	Premium	-
2022-11-14	Empery Asset Management, LP	UNCHANGED	Premium	Premium	Premium	Premium	235,000

Fund Name	# Shares	$ Value	% Port.
Empery Asset Management, LP	235,000	20,000	0.12%
Cruiser Capital Advisors, LLC	70,000	1,236	-
Tower Research Capital LLC (TRC)	-	-	-
MORGAN STANLEY	-	-	-
CITADEL ADVISORS LLC	-	-	-
Shay Capital LLC	-	-	-
CLEAR STREET LLC	-	-	-

Fund Name	$ Value	% Port.
Empery Asset Management, LP	20,000	0.12%
Tower Research Capital LLC (TRC)	-	-
MORGAN STANLEY	-	-
CITADEL ADVISORS LLC	-	-
Cruiser Capital Advisors, LLC	1,236	-
Shay Capital LLC	-	-
CLEAR STREET LLC	-	-

Fund Name	$ Sold
MORGAN STANLEY	-14,698
Tower Research Capital LLC (TRC)	-1,520
CITADEL ADVISORS LLC	-1,087
CLEAR STREET LLC	-1,000
Shay Capital LLC	-502

SQL - SeqLL Inc. Stock Price, Fair Value and News

Which funds bought or sold SQL recently?

Which funds are the top buyers of SQL?

Which funds have put a big percent of portfolio in SQL?

Trend of No. of funds that hold SQL

Changes in Positions

Investor Breakout

Investor Churn (# Increased Holdings)

Sold off